Invited Talks
- Kinross J. Mixed Reality. CogX, London June 2020.
- Kinross J. How surgeons will use data to inform intra-operative decision making. Intelligent Health. London, September 2020.
- Kinross J. The oncogenic microbiome – defining drivers and passengers in initiation and progression. The London Microbiome Meeting. October 2020.
- Kinross J. Leveraging the gut microbiome to improve clinical outcomes in cancer. Auckland, New Zealand. October 2020.
- Kinross J. How the microbiome will change colorectal surgery. International Bordeaux Colorectal Master Class. October 2020.
- Kinross J: Leveraging the gut microbiome to improve clinical outcomes in cancer. New Zealand Society of Oncology. October 2020.
- Kinross J. The Digital Surgeon. Association of Colorectal and Proctological Surgery. Edinburgh, September 2020.
- Kinross J. Listening to the patient’s gut. The power of patient generated data. Royal Society of Medicine. May 2020.
- Kinross J. Translational applications of the oncological microbiome in clinical practice. Stellenbosch University Microbiome Meeting. Stellenbosch, South Africa. November 2019
- Kinross J. Translational applications of the gut microbiome in surgery. The Dutch Surgical Society, Edinburgh September 2019
Videos
Collaborators
Guido Franzoso, M.D., Ph.D., Imperial College London, Inflammation and Signal Transduction in colorectal cancer, 2011 - 2014
Prof. O'Keefe, Pittsburgh School of medicine, Colorectal cancer, 2011
Dr. Tim Orchard, Imperial College, Inflammatory bowel disease, 2011
Dr. Tony Gordon, Imperial College, Sepsis, 2010
Prof. Glen Gibson, Reading food biosciences unit, Gut microbiome, 2007
Dr. Julian Marchesi, Cardiff School of Biosciences, Gut metagenomics
Research Student Supervision
Eng,D, Personalised diagnostics in inflammatory bowel disease
Mirnezami,R, Systems metabolism of colorectal cancer
Muirhead,L, Analysis of diathermy plumes by Mass Spectrometry in Surgery
Umrani,I, Using virtual worlds to enhance medical student training in the operating theatre.
Vernazza,J, Metabonomic profiling of secondary peritonitis